RAC 3.03% $1.76 race oncology ltd

RAC media coverage, page-1277

  1. 827 Posts.
    lightbulb Created with Sketch. 127
    Which basically means - they DO have evidence to support zantrene inhibiting FTO in humans, but now is not the right time to release the evidence.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.